Estrella Immunopharma (ESLA) traded down -6.7 % during a 24 hours period ending at 09:33 AM Central Europe on Tuesday 27th. One Estrella Immunopharma stock can currently be bought for about USD 0.92 on popular exchanges. Current supply of Estrella Immunopharma stocks is 40 mn. Estrella Immunopharma has a current market capitalization of USD 42.9 mn and approximately USD 2.4 mn worth of Estrella Immunopharma was traded on exchanges in the last 24 hours. Since last month end, Estrella Immunopharma has traded 113.23 % up. Simple moving average of last 200 days is at USD 0.99. The highest price of past 52 weeks was recorded at USD 3.15 on 11/04/2025. 52 weeks low was at USD 0.24 on 10/19/2026.
Here is how related stocks have performed in the past 24 hours:
Elicio Therapeutics (9HA.F) traded down -12.36 % and now trades at USD 1.7. Current market capitalisation for Elicio Therapeutics is USD 49.9 mn.
Novonix (GC3.F) traded up 2.7 % and now trades at EUR 0.05. Current market capitalisation for Novonix is EUR 45.6 mn.
Travelzoo (TZOO) traded up 0.99 % and now trades at USD 5.12. Current market capitalisation for Travelzoo is USD 51 mn. Travelzoo has a current price to earnings ratio of 125.44.
Datacentrex (DTCX) traded down -3.91 % and now trades at USD 1.23. Current market capitalisation for Datacentrex is USD 51.4 mn.
Xilio Therapeutics (XLO) traded down -3.43 % and now trades at USD 7.31. Xilio Therapeutics has a market capitalisation of USD 49.8 mn.
About Estrella Immunopharma
Estrella Immunopharma, Inc. is a preclinical-stage biopharmaceutical company based in Emeryville, United States. The company specializes in developing CD19 and CD22-targeted T-cell therapies to tackle treatment challenges for patients with blood cancers and solid tumors globally.